Adjuvant interferon alfa for melanoma

被引：0

作者：

Wilson, Kenneth S. ^{[1
]}

Attwell, Andrew ^{[1
]}

机构：

[1] British Columbia Canc Agcy, Vancouver Isl Ctr, Victoria, BC V8R 6V5, Canada

来源：

CURRENT ONCOLOGY | 2010年 / 17卷 / 03期

关键词：

Melanoma; adjuvant; interferon; HIGH-RISK MELANOMA; END;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：102 / 103

页数：2

共 6 条

[1] Adjuvant Interferon in High-Risk Melanoma: End of the Era? Reply [J].

Eggermont, Alexander M. M. ;

Bottomley, Andrew ;

Suciu, Stefan ;

Coens, Cornelis ;

Testori, Alessandro ;

Patel, Poulam ;

Spatz, Alan .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) :E17-E18

[2] Adjuvant Interferon in High-Risk Melanoma: End of the Era? [J].

Janku, Filip ;

Kurzrock, Razelle .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) :E15-E16

[3] High- and low-dose interferon alfa-2b in high-risk melanoma: First analysis of Intergroup Trial E1690/S9111/C9190 [J].

Kirkwood, JM ;

Ibrahim, JG ;

Sondak, VK ;

Richards, J ;

Flaherty, LE ;

Ernstoff, MS ;

Smith, TJ ;

Rao, U ;

Steele, M ;

Blum, RH .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (12) :2444-2458

[4] Randomized Phase III Study of 1 Month Versus 1 Year of Adjuvant High-Dose Interferon Alfa-2b in Patients With Resected High-Risk Melanoma [J].

Pectasides, Dimitrios ;

Dafni, Urania ;

Bafaloukos, Dimitrios ;

Skarlos, Dimosthenis ;

Polyzos, Aristidis ;

Tsoutsos, Dimosthenis ;

Kalofonos, Haralambos ;

Fountzilas, George ;

Panagiotou, Petros ;

Kokkalis, George ;

Papadopoulos, Othon ;

Castana, Ourania ;

Papadopoulos, Stefanos ;

Stavrinidis, Elias ;

Vourli, Georgia ;

Ioannovich, John ;

Gogas, Helen .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (06) :939-944

[5]

Wheatley K, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2007.13.3389

[6]

Wilson K, 2001, J CLIN ONCOL, V19, P4350

← 1 →